Jazz Pharmaceuticals plc — Director's Dealing 2013

Mar 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-03-05

Reporting Person: FALBERG KATHRYN E (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-05	Ordinary Shares	M	44216	$7.35	Acquired	133417	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-05	Incentive Stock Option (right to buy)	$7.35	M	44216	Disposed	2019-12-06	Ordinary Shares (44216)	Direct

Footnotes

F1: Includes 419 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2012.

F2: Following the reported transaction, the remaining ordinary shares subject to this incentive stock option vest monthly in equal installments from April 1, 2013 to December 1, 2013.